Several new 3-(indazol-3-yl)-quinazolin-4(3H)-one and 3-(indazol-3-yl)-benzotriazin-4(3H)-one derivatives 5 and 6 were synthesized and tested for their in vitro antiproliferative activity against Raji, K562, and K562-R cell lines. The pharmacological screening showed that some 2, 6, or 7-substituted
The Structures of Indazolin-3-one (=1,2-Dihydro-3H-indazol-3-one) and 7-Nitroindazolin-3-one
✍ Scribed by Rosa M. Claramunt; Dionisia Sanz; Concepción López; Elena Pinilla; M. Rosario Torres; José Elguero; Pierre Nioche; C. S. Raman
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- German
- Weight
- 311 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0018-019X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The existence of polymorphism in parent indazolin‐3‐one (=1,2‐dihydro‐3__H__‐indazol‐3‐one; 1) is reported as well as an X‐ray and NMR CPMAS study establishing that its 7‐nitro derivative 2 exists as the 3‐hydroxy tautomer. Absolute shieldings calculated at the GIAO/B3LYP/6‐311++G(d,p) level were used to determine the tautomeric oxo/hydroxy equilibrium in solution, i.e., always the 1__H__‐indazol‐3‐ol tautomer predominates.
📜 SIMILAR VOLUMES
## Abstract The title compound 4 is synthesized in 8 steps by cyclization of __N__‐tosylglycinate 5 with vinyl ketone 6. After elimination of water and sulfinic acid the pyrrolecarboxylate 9 is obtained which, on __N__‐alkylation with ethyl acrylate, Dieckmann cyclization, saponification and decarb